These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 17804567
1. Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome. Guilpain P, Auclair JF, Tamby MC, Servettaz A, Mahr A, Weill B, Guillevin L, Mouthon L. Ann N Y Acad Sci; 2007 Jun; 1107():392-9. PubMed ID: 17804567 [Abstract] [Full Text] [Related]
2. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Schmitt WH, Csernok E, Kobayashi S, Klinkenborg A, Reinhold-Keller E, Gross WL. Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572 [Abstract] [Full Text] [Related]
3. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity. Polzer K, Karonitsch T, Neumann T, Eger G, Haberler C, Soleiman A, Hellmich B, Csernok E, Distler J, Manger B, Redlich K, Schett G, Zwerina J. Rheumatology (Oxford); 2008 Jun; 47(6):804-8. PubMed ID: 18397958 [Abstract] [Full Text] [Related]
4. Increased serum high mobility group box-1 level in Churg-Strauss syndrome. Taira T, Matsuyama W, Mitsuyama H, Kawahara KI, Higashimoto I, Maruyama I, Osame M, Arimura K. Clin Exp Immunol; 2007 May; 148(2):241-7. PubMed ID: 17437420 [Abstract] [Full Text] [Related]
5. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome. Jakiela B, Szczeklik W, Sokolowska B, Mastalerz L, Sanak M, Plutecka H, Szczeklik A. Rheumatology (Oxford); 2009 Oct; 48(10):1202-7. PubMed ID: 19643727 [Abstract] [Full Text] [Related]
9. Serum eosinophilic cationic protein: is there a role in respiratory disorders? Peona V, De Amici M, Quaglini S, Bellaviti G, Castellazzi AM, Marseglia G, Ciprandi G. J Asthma; 2010 Mar; 47(2):131-4. PubMed ID: 20170318 [Abstract] [Full Text] [Related]
10. Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation. Malm-Erjefält M, Greiff L, Ankerst J, Andersson M, Wallengren J, Cardell LO, Rak S, Persson CG, Erjefält JS. Clin Exp Allergy; 2005 Oct; 35(10):1334-40. PubMed ID: 16238793 [Abstract] [Full Text] [Related]
13. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents. Niccoli G, Schiavino D, Belloni F, Ferrante G, La Torre G, Conte M, Cosentino N, Montone RA, Sabato V, Burzotta F, Trani C, Leone AM, Porto I, Pieroni M, Patriarca G, Crea F. Eur Heart J; 2009 Jun; 30(11):1340-7. PubMed ID: 19383735 [Abstract] [Full Text] [Related]
14. Serum eosinophil cationic protein in children with atopic dermatitis. Murat-Susić S, Lipozencić J, Zizić V, Husar K, Marinović B. Int J Dermatol; 2006 Oct; 45(10):1156-60. PubMed ID: 17040428 [Abstract] [Full Text] [Related]
15. Correlation of eosinophil cationic protein with severity of asthma. Badar A, Saeed W, Hussain MM, Aslam M. J Ayub Med Coll Abbottabad; 2004 Oct; 16(3):66-71. PubMed ID: 15631377 [Abstract] [Full Text] [Related]
16. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome. Kim S, Marigowda G, Oren E, Israel E, Wechsler ME. J Allergy Clin Immunol; 2010 Jun; 125(6):1336-43. PubMed ID: 20513524 [Abstract] [Full Text] [Related]